Outcome in severe pediatric Guillain-Barré syndrome after immunotherapy or supportive care
Authors:
- 1 April 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurology
- Vol. 52 (7) , 1494
Abstract
Article abstract We reviewed duration of illness in 26 children with severe pediatric Guillain-Barré syndrome (GBS) during two contiguous 8-year periods that represent a “non-treatment era” of supportive care alone or a “treatment era” of supportive care plus either plasma exchange or intravenous immunoglobulin intervention. Our findings of similar recovery times in each treatment group suggest that immunotherapy in severe pediatric GBS may be less effective than in adult GBS, or effective only when given to certain patients very early in the course of the illness.Keywords
This publication has 10 references indexed in Scilit:
- The current place of high-dose immunoglobulins in the treatment of neuromuscular disordersMuscle & Nerve, 1997
- Natural history and treatment effects in Guillain-Barre syndrome: a multicentre study.Archives of Disease in Childhood, 1996
- Guillain-Barré syndrome in childhood: Natural course and efficacy of plasmapheresisPediatric Neurology, 1993
- The Guillain–Barré SyndromeNew England Journal of Medicine, 1992
- Guillain–Barré syndrome in children: Clinical course, electrodiagnosis, and prognosisMuscle & Nerve, 1992
- Occurrence, clinical manifestations, and prognosis of Guillain-Barre syndrome.Archives of Disease in Childhood, 1991
- The role of plasmapheresis in childhood guillain‐barré syndromeAnnals of Neurology, 1990
- Prognosis in Guillain-Barre syndrome.Archives of Disease in Childhood, 1987
- Prognosis in severe Guillain-Barre syndrome.Archives of Disease in Childhood, 1987
- CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHYThe Lancet, 1978